Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
Nucleic Acids Res
; 48(1): 130-140, 2020 01 10.
Article
in En
| MEDLINE
| ID: mdl-31713617
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Schwann Cells
/
Charcot-Marie-Tooth Disease
/
TATA Box
/
Molecular Targeted Therapy
/
Myelin Proteins
/
Myelin Sheath
Limits:
Animals
/
Humans
Language:
En
Journal:
Nucleic Acids Res
Year:
2020
Type:
Article